Documents
Application Sponsors
ANDA 040541 | MYLAN INSTITUTIONAL | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | INJECTABLE;INJECTION | 20MG/2ML (10MG/ML) | 0 | SOTRADECOL | SODIUM TETRADECYL SULFATE |
002 | INJECTABLE;INJECTION | 60MG/2ML (30MG/ML) | 0 | SOTRADECOL | SODIUM TETRADECYL SULFATE |
FDA Submissions
| ORIG | 1 | AP | 2004-11-12 | |
LABELING; Labeling | SUPPL | 4 | AP | 2008-05-30 | |
LABELING; Labeling | SUPPL | 14 | AP | 2018-03-01 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2019-05-22 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 1 |
SUPPL | 14 | Null | 15 |
SUPPL | 15 | Null | 15 |
TE Codes
CDER Filings
MYLAN INSTITUTIONAL
cder:Array
(
[0] => Array
(
[ApplNo] => 40541
[companyName] => MYLAN INSTITUTIONAL
[docInserts] => ["",""]
[products] => [{"drugName":"SOTRADECOL","activeIngredients":"SODIUM TETRADECYL SULFATE","strength":"20MG\/2ML (10MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"},{"drugName":"SOTRADECOL","activeIngredients":"SODIUM TETRADECYL SULFATE","strength":"60MG\/2ML (30MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"SOTRADECOL","submission":"SODIUM TETRADECYL SULFATE","actionType":"20MG\/2ML (10MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"SOTRADECOL","submission":"SODIUM TETRADECYL SULFATE","actionType":"60MG\/2ML (30MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)